Evidence map›Paper›PMID 30805404›Full record

ArticleReports of biochemistry & molecular biology2019

Evaluating the Role of

Majid Hoseini, Mehdi Sahmani, Farshad Foroughi, Yousef Khazaei Monfared, Mehdi Azad

Open access · greenAbstract read
In one paragraph

Article in Reports of biochemistry & molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Majid HoseiniDepartment of medical biotechnology, School of Paramedicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi SahmaniCellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Farshad ForoughiDepartment of Immunology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Yousef Khazaei MonfaredDepartment of medical biotechnology, School of Paramedicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi AzadDepartment of Medical laboratory sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Qazvin University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypercoagulable states (HS) can result from several different inherited and acquired disease conditions that cause abnormalities in the genes, proteins and cellular factors involved in the coagulation cascade. Novel insight into the molecular mechanisms involved in the coagulation pathways can provide a framework to develop improved therapeutics to treat patients with coagulation disorders. Therefore, investigating the genetic abnormalities present in patients with coagulation disorders can offer critical insight into disease pathogenesis. Our study aimed to assess the promoter methylation patterns of the phosphatase and tensin homologue (

methodsTo measure the differences between the mRNA expression of

resultsOur findings reveal

conclusionSince no differences in the methylation patterns of the PTEN gene was found between HS patients and controls, this suggests that DNA methylation of the

Indexed as

Hyperquagulable StatePromoter methylationPTEN

Identifiers

PMID30805404
PMCPMC6374066
OpenAlexW2907444507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.